Capsule drug for treating heart failure and preparation method of capsule drug
A technology of heart failure and capsules, which is applied in the direction of capsule delivery, drug combination, pharmaceutical formula, etc., to achieve good therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0031] A capsule medicine for the treatment of heart failure, characterized in that the components of the medicine and their mass parts ratio are as follows:
[0032] Red Ginseng 80g, Polyporus 150g, Aconite (manufactured) 110g, Psoralen 120g, Poria cocos 120g, Chuanxiong 95g, Tinglizi 120g, Guizhi 90g, Panax notoginseng 80g, Radix Paeoniae Rubra 110g, Ophiopogon japonicus 170g, Spatholobus 200g .
Embodiment 2
[0034] A capsule medicine for the treatment of heart failure, characterized in that the components of the medicine and their mass parts ratio are as follows:
[0035] Red Ginseng 90g, Polyporus 170g, Aconite (manufactured) 130g, Psoralen 140g, Poria cocos 140g, Chuanxiong 105g, Tinglizi 140g, Guizhi 105g, Panax notoginseng 90g, Radix Paeoniae Rubra 130g, Ophiopogon japonicus 200g, Spatholobus 230g .
Embodiment 3
[0037] A capsule medicine for the treatment of heart failure, characterized in that the components of the medicine and their mass parts ratio are as follows:
[0038] Red Ginseng 100g, Polyporus 200g, Aconite (manufactured) 150g, Psoralen 160g, Poria cocos 160g, Chuanxiong 120g, Tinglizi 160g, Guizhi 120g, Panax notoginseng 100g, Radix Paeoniae Rubra 150g, Ophiopogon japonicus 220g, Caulis Spatholobus 260g .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap